Morgan Stanley 13D and 13G filings for 10x Genomics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-12-08 4:37 pm Sale |
2023-11-30 | 13G | 10x Genomics, Inc. TXG |
MORGAN STANLEY MS |
3,630,398 3.500% |
-1,509,063 (-29.36%) |
Filing |
| 2023-07-10 4:38 pm Sale |
2023-06-30 | 13G | 10x Genomics, Inc. TXG |
MORGAN STANLEY MS |
5,139,461 5.200% |
-4,755,518 (-48.06%) |
Filing |
| 2023-02-08 11:17 am Sale |
2022-12-30 | 13G | 10x Genomics, Inc. TXG |
MORGAN STANLEY MS |
9,894,979 10.400% |
-446,774 (-4.32%) |
Filing |
| 2022-09-12 4:29 pm Purchase |
2022-08-31 | 13G | 10x Genomics, Inc. TXG |
MORGAN STANLEY MS |
10,341,753 10.900% |
5,732,995 (+124.39%) |
Filing |
| 2022-02-09 10:56 am Sale |
2021-12-31 | 13G | 10x Genomics, Inc. TXG |
MORGAN STANLEY MS |
4,608,758 5.000% |
-1,306,776 (-22.09%) |
Filing |
| 2021-02-10 10:23 am Sale |
2020-12-31 | 13G | 10x Genomics, Inc. TXG |
MORGAN STANLEY MS |
5,915,534 7.400% |
-877,284 (-12.91%) |
Filing |
| 2020-05-08 4:19 pm Purchase |
2020-04-30 | 13G | 10x Genomics, Inc. TXG |
MORGAN STANLEY MS |
6,792,818 12.100% |
1,774,572 (+35.36%) |
Filing |